Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-13
DOI
10.3389/fcimb.2020.606412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
- (2020) Lucia Mundo et al. MODERN PATHOLOGY
- DNA methylation enzymes and PRC1 restrict B-cell Epstein–Barr virus oncoprotein expression
- (2020) Rui Guo et al. Nature Microbiology
- Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma
- (2019) Bruno M. Grande et al. BLOOD
- Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC subtype diffuse large B cell lymphoma
- (2019) Martina Vockerodt et al. JOURNAL OF PATHOLOGY
- Gammaherpesvirus RNAs Come Full Circle
- (2019) Nathan A. Ungerleider et al. mBio
- The whole genome landscape of Burkitt lymphoma subtypes
- (2019) Razvan I. Panea et al. BLOOD
- EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins
- (2019) Leah Fitzsimmons et al. CELL DEATH AND DIFFERENTIATION
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
- (2019) Catherine de Martel et al. Lancet Global Health
- A broad atlas of somatic hypermutation allows prediction of activation-induced deaminase targets
- (2018) Ángel F. Álvarez-Prado et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
- (2017) Marius Rohde et al. HAEMATOLOGICA
- MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity
- (2017) Manuel Albanese et al. JOURNAL OF VIROLOGY
- Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type–Specific Differences
- (2017) Yasin Kaymaz et al. MOLECULAR CANCER RESEARCH
- AID Recognizes Structured DNA for Class Switch Recombination
- (2017) Qi Qiao et al. MOLECULAR CELL
- Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet
- (2017) P.E. Bunney et al. PHYSIOLOGY & BEHAVIOR
- The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers
- (2017) Burak H. Alver et al. Nature Communications
- An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation
- (2017) Yonggang Pei et al. PLoS Pathogens
- Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection
- (2017) Alexander M Price et al. eLife
- Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases
- (2017) Lucia Mundo et al. Frontiers in Microbiology
- Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
- (2017) Marius Rohde et al. HAEMATOLOGICA
- Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines
- (2017) Hector Hernandez-Vargas et al. Scientific Reports
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells
- (2016) Jens S. Kalchschmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
- (2016) Jill M. Brooks et al. PLoS Pathogens
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- Epstein-Barr Virus Oncoprotein Super-enhancers Control B Cell Growth
- (2015) Hufeng Zhou et al. Cell Host & Microbe
- Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites
- (2015) Anqi Wang et al. JOURNAL OF VIROLOGY
- Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma
- (2015) Francesco Abate et al. PLoS Pathogens
- Counteracting Effects of Cellular Notch and Epstein-Barr Virus EBNA2: Implications for Stromal Effects on Virus-Host Interactions
- (2014) M. Rowe et al. JOURNAL OF VIROLOGY
- MicroRNA miR-BART20-5p Stabilizes Epstein-Barr Virus Latency by Directly Targeting BZLF1 and BRLF1
- (2014) Y.-J. Jung et al. JOURNAL OF VIROLOGY
- EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN
- (2014) L-M Cai et al. ONCOGENE
- Multiple functions are mediated by the miRNAs of Epstein-Barr virus
- (2014) Malika Kuzembayeva et al. Current Opinion in Virology
- The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma
- (2014) Maria Ambrosio et al. Infectious Agents and Cancer
- The Epstein–Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins
- (2013) Giuseppe Coppotelli et al. NUCLEIC ACIDS RESEARCH
- Epstein–Barr virus maintains lymphomas via its miRNAs
- (2013) D T Vereide et al. ONCOGENE
- Epstein-Barr Virus Nuclear Antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A
- (2013) S. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8
- (2013) Shuvomoy Banerjee et al. PLoS Pathogens
- Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes
- (2012) L. Giulino-Roth et al. BLOOD
- Epidemiology: clues to the pathogenesis of Burkitt lymphoma
- (2012) Ian Magrath BRITISH JOURNAL OF HAEMATOLOGY
- Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis
- (2012) Sandrine Sander et al. CANCER CELL
- EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency
- (2012) Kasandra J Riley et al. EMBO JOURNAL
- BCL6 positively regulates AID and germinal center gene expression via repression of miR-155
- (2012) Katia Basso et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature
- (2012) G. L. Kelly et al. JOURNAL OF VIROLOGY
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
- (2012) Roland Schmitz et al. NATURE
- The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
- (2012) Rebecca L. Skalsky et al. PLoS Pathogens
- FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
- (2011) Shanshan Duan et al. NATURE
- Lymphomas differ in their dependence on Epstein-Barr virus
- (2010) D. T. Vereide et al. BLOOD
- Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric Carcinoma
- (2009) R. Hino et al. CANCER RESEARCH
- Identifying Sites Bound by Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) in the Human Genome: Defining a Position-Weighted Matrix To Predict Sites Bound by EBNA1 in Viral Genomes
- (2009) L. R. Dresang et al. JOURNAL OF VIROLOGY
- Epstein-Barr Virus-Encoded Bcl-2 Homologue Functions as a Survival Factor in Wp-Restricted Burkitt Lymphoma Cell Line P3HR-1
- (2009) A. Watanabe et al. JOURNAL OF VIROLOGY
- The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim
- (2009) A. L. Desbien et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The microRNAs of Epstein–Barr Virus are expressed at dramatically differing levels among cell lines
- (2009) Zachary L. Pratt et al. VIROLOGY
- An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link
- (2009) Gemma L. Kelly et al. PLoS Pathogens
- EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3
- (2008) T. Xia et al. CANCER RESEARCH
- MicroRNA-155 Is a Negative Regulator of Activation-Induced Cytidine Deaminase
- (2008) Grace Teng et al. IMMUNITY
- MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation
- (2008) Yair Dorsett et al. IMMUNITY
- Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-γ T cell responses
- (2008) Ann M. Moormann et al. INTERNATIONAL JOURNAL OF CANCER
- Notch and BCR signaling synergistically promote the proliferation of Raji B-lymphoma cells
- (2008) Fei He et al. LEUKEMIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now